167 related articles for article (PubMed ID: 2021942)
1. Carcinoma induction following direct in situ transfer of v-Ha-ras into rat mammary epithelial cells using replication-defective retrovirus vectors.
Wang BC; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
Cancer Res; 1991 May; 51(10):2642-8. PubMed ID: 2021942
[TBL] [Abstract][Full Text] [Related]
2. Overcoming the activity of mammary carcinoma suppressor gene in Copenhagen rats by v-H-ras oncogene transfer into mammary epithelial cells in situ.
Wang B; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
Cancer Res; 1991 Oct; 51(19):5298-303. PubMed ID: 1913652
[TBL] [Abstract][Full Text] [Related]
3. Limonene chemoprevention of mammary carcinoma induction following direct in situ transfer of v-Ha-ras.
Gould MN; Moore CJ; Zhang R; Wang B; Kennan WS; Haag JD
Cancer Res; 1994 Jul; 54(13):3540-3. PubMed ID: 8012978
[TBL] [Abstract][Full Text] [Related]
4. Defective retrovirus insertion activates c-Ha-ras protooncogene in an MNU-induced rat mammary carcinoma.
Bera TK; Tsukamoto T; Panda DK; Huang T; Guzman RC; Hwang SI; Nandi S
Biochem Biophys Res Commun; 1998 Jul; 248(3):835-40. PubMed ID: 9704014
[TBL] [Abstract][Full Text] [Related]
5. Frequent induction of mammary carcinomas following neu oncogene transfer into in situ mammary epithelial cells of susceptible and resistant rat strains.
Wang B; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
Cancer Res; 1991 Oct; 51(20):5649-54. PubMed ID: 1913683
[TBL] [Abstract][Full Text] [Related]
6. Difference in the response of neu and ras oncogene-induced rat mammary carcinomas to early and late ovariectomy.
Wang B; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
Cancer Res; 1992 Aug; 52(15):4102-5. PubMed ID: 1353410
[TBL] [Abstract][Full Text] [Related]
7. Isolation of oncogenes from rat mammary tumors by a highly efficient retrovirus expression cloning system.
Tsukamoto T; Huang T; Guzman RC; Chen X; Pascual RV; Kitamura T; Nandi S
Biochem Biophys Res Commun; 1999 Nov; 265(1):7-12. PubMed ID: 10548482
[TBL] [Abstract][Full Text] [Related]
8. Viral Ha-ras mediated mammary tumor progression.
Aguilar-Cordova E; Strange R; Young LJ; Billy HT; Gumerlock PH; Cardiff RD
Oncogene; 1991 Sep; 6(9):1601-7. PubMed ID: 1923527
[TBL] [Abstract][Full Text] [Related]
9. The genetic penetrance of the activated neu oncogene for the induction of mammary cancer in vivo.
Tai YT; Gould MN
Oncogene; 1997 Jun; 14(22):2701-7. PubMed ID: 9178768
[TBL] [Abstract][Full Text] [Related]
10. Transfection of activated Ha-ras protooncogenes causes mouse mammary hyperplasia.
Miyamoto S; Guzman RC; Shiurba RA; Firestone GL; Nandi S
Cancer Res; 1990 Sep; 50(18):6010-4. PubMed ID: 2203525
[TBL] [Abstract][Full Text] [Related]
11. Harvey-ras mediated neoplastic development in the mouse mammary gland.
Strange R; Aguilar-Cordova E; Young LJ; Billy HT; Dandekar S; Cardiff RD
Oncogene; 1989 Mar; 4(3):309-15. PubMed ID: 2784851
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 is necessary but not sufficient for anchorage-independent growth of rat mammary tumor cells and is associated with resistance of the Copenhagen rat to mammary carcinogenesis.
Li YJ; Song R; Korkola JE; Archer MC; Ben-David Y
Oncogene; 2003 May; 22(22):3452-62. PubMed ID: 12776197
[TBL] [Abstract][Full Text] [Related]
13. Harvey ras results in a higher frequency of mammary carcinomas than Kirsten ras after direct retroviral transfer into the rat mammary gland.
Thompson TA; Kim K; Gould MN
Cancer Res; 1998 Nov; 58(22):5097-104. PubMed ID: 9823318
[TBL] [Abstract][Full Text] [Related]
14. Reduction in the frequency of activated ras oncogenes in rat mammary carcinomas with increasing N-methyl-N-nitrosourea doses or increasing prolactin levels.
Zhang R; Haag JD; Gould MN
Cancer Res; 1990 Jul; 50(14):4286-90. PubMed ID: 2194653
[TBL] [Abstract][Full Text] [Related]
15. The transformation of primary and established mouse mammary epithelial cells by p21-ras is concentration dependent.
Redmond SM; Reichmann E; Müller RG; Friis RR; Groner B; Hynes NE
Oncogene; 1988 Mar; 2(3):259-65. PubMed ID: 3127778
[TBL] [Abstract][Full Text] [Related]
16. Ha-ras and v-raf oncogenes, but not int-2 and c-myc, interfere with the lactogenic hormone dependent activation of the mammary gland specific transcription factor.
Happ B; Hynes NE; Groner B
Cell Growth Differ; 1993 Jan; 4(1):9-15. PubMed ID: 8424907
[TBL] [Abstract][Full Text] [Related]
17. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras.
Tokumitsu Y; Nakano S; Ueno H; Niho Y
J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral-mediated gene transfer into primary human and mouse mammary epithelial cells in vitro and in vivo.
Yang J; Tsukamoto T; Popnikolov N; Guzman RC; Chen X; Yang JH; Nandi S
Cancer Lett; 1995 Nov; 98(1):9-17. PubMed ID: 8529212
[TBL] [Abstract][Full Text] [Related]
19. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
[TBL] [Abstract][Full Text] [Related]
20. Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene.
Kyprianou N; Isaacs JT
Cancer Res; 1990 Mar; 50(5):1449-54. PubMed ID: 2105838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
